Education
About Us
Working with TipRanks
Follow Us
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
TMDX Analyst Ratings
Moderate Buy
6 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TMDX Stock 12 Month Forecast
Average Price Target
$100.71
▲(43.22% Upside)
| Highest Price Target$125.00 | Average Price Target$100.71 | Lowest Price Target$80.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Needham
Reiterated
03/26/25
Canaccord Genuity
Reiterated
03/10/25
Piper Sandler
Reiterated
03/04/25
Morgan Stanley
Reiterated
03/03/25
William Blair
Reiterated
02/28/25
J.P. Morgan
Reiterated
02/28/25
TD Cowen
Reiterated
02/27/25
Oppenheimer
Reiterated
02/03/25
Robert W. Baird
$150→$120
Buy
70.65%
Upside
Reiterated
12/11/24
TransMedics price target lowered to $120 from $150 at BairdTransMedics price target lowered to $120 from $150 at Baird
Stephens
$151→$178
Buy
153.13%
Upside
Reiterated
08/02/24
TransMedics Group (TMDX) PT Raised to $178 at StephensStephens analyst George Sellers raised the price target on TransMedics Group (NASDAQ: TMDX) to $178.00 (from $151.00) while maintaining a Overweight rating.
Unknown Analyst
Not Ranked
C.L. King
$161
Buy
128.95%
Upside
Initiated
06/06/24
CL King starts TransMedics Group (TMDX) at BuyCL King initiates coverage on TransMedics Group (NASDAQ: TMDX) with a Buy rating and a price target of $161.00.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Needham
Reiterated
03/26/25
Canaccord Genuity
Reiterated
03/10/25
Piper Sandler
Reiterated
03/04/25
Morgan Stanley
Reiterated
03/03/25
William Blair
Reiterated
02/28/25
J.P. Morgan
Reiterated
02/28/25
TD Cowen
Reiterated
02/27/25
Oppenheimer
Reiterated
02/03/25
Robert W. Baird
$150→$120
Buy
70.65%
Upside
Reiterated
12/11/24
TransMedics price target lowered to $120 from $150 at BairdTransMedics price target lowered to $120 from $150 at Baird
Stephens
$151→$178
Buy
153.13%
Upside
Reiterated
08/02/24
TransMedics Group (TMDX) PT Raised to $178 at StephensStephens analyst George Sellers raised the price target on TransMedics Group (NASDAQ: TMDX) to $178.00 (from $151.00) while maintaining a Overweight rating.
Unknown Analyst
Not Ranked
C.L. King
$161
Buy
128.95%
Upside
Initiated
06/06/24
CL King starts TransMedics Group (TMDX) at BuyCL King initiates coverage on TransMedics Group (NASDAQ: TMDX) with a Buy rating and a price target of $161.00.
TMDX Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
5
11
11
11
6
Buy
17
16
9
10
7
Hold
4
9
7
8
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
36
27
29
18
Each month's total comprises the sum of three months' worth of ratings.
TMDX Financial Forecast
TMDX Stock Forecast FAQ
What is TMDX’s average 12-month price target, according to analysts?
Based on analyst ratings, TransMedics Group Inc’s 12-month average price target is $100.71.
What is TMDX’s upside potential, based on the analysts’ average price target?
TransMedics Group Inc has 43.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TMDX a Buy, Sell or Hold?
TransMedics Group Inc has a consensus rating of Moderate Buy which is based on 6 buy ratings, 3 hold ratings and 0 sell ratings.
What is TransMedics Group Inc’s price target?
The average price target for TransMedics Group Inc is $100.71. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $125.00 ,the lowest forecast is $80.00. The average price target represents 43.22% Increase from the current price of $70.32.
The highest analyst price target is $125.00 ,the lowest forecast is $80.00. The average price target represents 43.22% Increase from the current price of $70.32.
What do analysts say about TransMedics Group Inc?
TransMedics Group Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of TMDX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.